We are live on ! Find out more
Verition Fund Management

Verition Fund Management Portfolio holdings

AUM $15.4B
1-Year Est. Return 30.69%
This Fund
S&P 500
This Quarter Est. Return
+5.88%
1 Year Est. Return
+30.69%
3 Year Est. Return
+85.73%
5 Year Est. Return
+92.38%
10 Year Est. Return
+282.97%
AUM
$563M
AUM Growth
-$98.9M
Cap. Flow
-$173M
Cap. Flow %
-30.69%
Top 10 Hldgs %
40.45%
Holding
803
New
294
Increased
64
Reduced
105
Closed
311

Sector Composition

Rank Sector Weight
1 Technology 14.9%
2 Healthcare 3.89%
3 Industrials 3.57%
4 Financials 3.28%
5 Consumer Discretionary 2.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XIN
426
DELISTED
Xinyuan Real Estate
XIN
$97K 0.02%
+1,805
New +$109K
GRT
427
DELISTED
GLIMCHER REALTY TRUST
GRT
$94K 0.02%
+10,047
New +$98.6K
DNDN
428
DELISTED
DENDREON CORPORATION
DNDN
$94K 0.02%
+31,432
New +$88.4K
IDIX
429
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$94K 0.02%
+15,781
New +$73K
MNKD icon
430
MannKind Corp
MNKD
$1.22B
$93K 0.02%
+3,555
New +$90.4K
HZNP
431
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$91K 0.02%
+11,987
New +$64.6K
MWW
432
DELISTED
Monster Worldwide Inc
MWW
$91K 0.02%
+12,768
New +$66.7K
MXWL
433
DELISTED
Maxwell Technologies Inc
MXWL
$89K 0.02%
+11,440
New +$89.1K
NTWK icon
434
NetSol Technologies
NTWK
$51.1M
$88K 0.02%
+15,149
New +$94.3K
ARNA
435
DELISTED
Arena Pharmaceuticals Inc
ARNA
$87K 0.02%
+1,479
New +$77.3K
ACHN
436
DELISTED
Achillion Pharmaceuticals
ACHN
$86K 0.02%
+25,865
New +$75K
AXAS
437
DELISTED
Abraxas Petroleum Corp
AXAS
$85K 0.02%
+1,300
New +$84.1K
OPK icon
438
PUT
Opko Health
OPK
$936M
$84K 0.01%
+10,000
New +$101K
FTEK icon
439
Fuel Tech
FTEK
$47.4M
$82K 0.01%
+11,571
New +$70.5K
ANH
440
DELISTED
Anworth Mortgage Asset Corporation
ANH
$80K 0.01%
+18,959
New +$85.3K
BLDR icon
441
Builders FirstSource
BLDR
$7.82B
$78K 0.01%
+10,978
New +$74.5K
CRDC
442
DELISTED
CARDICA INC COM NEW (DE)
CRDC
$78K 0.01%
8,000
NVAX icon
443
Novavax
NVAX
$1.23B
$77K 0.01%
+755
New +$53.3K
ATHE
444
Alterity Therapeutics
ATHE
$84.6M
$71K 0.01%
+168
New +$50.3K
BGC icon
445
BGC Group
BGC
$5.65B
$68K 0.01%
+17,391
New +$63.3K
RAD
446
DELISTED
Rite Aid Corporation
RAD
$68K 0.01%
+674
New +$71.7K
HERO
447
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
$67K 0.01%
+10,193
New +$68.8K
LIOX
448
DELISTED
Lionbridge Technologies
LIOX
$66K 0.01%
+11,043
New +$55.5K
RSO
449
DELISTED
Resource Capital Corp.
RSO
$63K 0.01%
+2,664
New +$63.6K
ANV
450
DELISTED
Allied Nevada Gold Corp
ANV
$60K 0.01%
+16,843
New +$63.2K

Similar funds

Verition Fund Management's Q4 2013 Portfolio in Review

As of Q4 2013, Verition Fund Management held 803 positions worth $563M, down 15% from $661M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Verition Fund Management withdrew a net $173M in Q4 2013, closing 311 positions and reducing 105 holdings. Its most notable exit was TMS INTERNATIONAL CORP CLASS A COM STK, an estimated $5.95M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 13% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Verition Fund Management opened a new position in iShares iBoxx $ High Yield Corporate Bond ETF worth $20M.

  • Verition Fund Management's largest Q4 2013 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 215,010 shares worth $20M.
  • Verition Fund Management added most to Altera Corp in Q4 2013, an estimated $3.74M increase.
  • Verition Fund Management's biggest Q4 2013 reduction was VNET Group, cutting an estimated $6.25M.
  • Verition Fund Management fully exited TMS INTERNATIONAL CORP CLASS A COM STK in Q4 2013, selling an estimated $5.95M.
  • Verition Fund Management's ten largest holdings make up 40% of its $563M portfolio in Q4 2013.
  • Verition Fund Management opened 294 new positions and closed 311 in Q4 2013.
  • Verition Fund Management's portfolio value fell 15% quarter-over-quarter to $563M.

Based on Verition Fund Management's 13F filing for Q4 2013, filed 14 Feb 2014.